{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:26Z","timestamp":1790735906617,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tinea capitis is a common cutaneous infection of the scalp and hair follicles, typically diagnosed by direct examination and culture. Treatment with oral antifungals is usually withheld until mycology results are available. In Israel, African refugee children demonstrate higher susceptibility to Tinea capitis and generally fail to undergo follow-up evaluations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study aimed to identify the clinical characteristics and treatment responses of refugee children in Israel with Tinea capitis, in order to formulate a treatment plan for primary care physicians. To this end, demographic, clinical and laboratory data were extracted from the electronic medical records of 76 refugee children presenting with Tinea capitis during 2016\u20132017. All measured variables and derived parameters are presented using descriptive statistics. The correlation between background clinical and demographic data and Tinea capitis diagnosis was assessed using the chi-squared and Wilcoxon tests. Correlations between demographic\/clinical\/laboratory characteristics and other types of fungi or other important findings were assessed using a T-test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Scaling was the most common clinical finding. Cultures were positive in 64 (84%) and direct examination in 65 (85%) cases, with a positive correlation between the methods in 75% of cases. The most common fungal strain was <jats:italic>T. violaceum<\/jats:italic>. Fluconazole treatment failed in 27% of cases. Griseofulvin 50\u2009mg\/kg\/day was administered to 74 (97%) children, and induced clinical responses. No side effects were reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The key aim of this study was to emphasize the importance of diagnosis and treatment of these immigrant children by their primary pediatric doctor since it takes, an average of 4.3\u2009months until they visit a dermatologist. During this critical time period, the scalp can become severely and permanently damaged, and the infection can become systemic or cause an outbreak within the entire community. In conclusion, we recommend to relate to scaly scalp in high-risk populations as Tinea capitis, and to treat with griseofulvin at a dosage of up to 50\u2009mg\/kg\/day, starting from the first presentation to the pediatrician.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02813-x","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T05:02:46Z","timestamp":1629954166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach"],"prefix":"10.1186","volume":"21","author":[{"given":"Riad","family":"Kassem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahel","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Nitzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Azrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"1","key":"2813_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2133.2000.03530.x","volume":"143","author":"EM Higgins","year":"2000","unstructured":"Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000;143(1):53\u20138. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03530.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2813_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/mmy.38.4.255.287","volume":"38","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Summerbell RC. Tinea capitis. Med Mycol. 2000;38(4):255\u201387. https:\/\/doi.org\/10.1080\/mmy.38.4.255.287.","journal-title":"Med Mycol"},{"issue":"3","key":"2813_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1525-1470.1999.00050.x","volume":"l16","author":"AK Gupta","year":"1999","unstructured":"Gupta AK, Hofstader SL, Adam P, Summerbell RC. Tinea capitis: an overview with emphasis on management. Pediatr Dermato. 1999;l16(3):171\u201389. https:\/\/doi.org\/10.1046\/j.1525-1470.1999.00050.x.","journal-title":"Pediatr Dermato"},{"issue":"1","key":"2813_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0190-9622(00)90001-x","volume":"42","author":"BE Elewski","year":"2000","unstructured":"Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000;42(1):1\u201320. https:\/\/doi.org\/10.1016\/s0190-9622(00)90001-x.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2813_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/ijd.14352","volume":"58","author":"KV Grigoryan","year":"2019","unstructured":"Grigoryan KV, Tollefson MM, Olson MA, Newman CC. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States. Int J Dermatol. 2019;58(8):912\u20135. https:\/\/doi.org\/10.1111\/ijd.14352.","journal-title":"Int J Dermatol"},{"issue":"1\u20132","key":"2813_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11046-016-0058-8","volume":"182","author":"RJ Hay","year":"2017","unstructured":"Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182(1\u20132):87\u201393. https:\/\/doi.org\/10.1007\/s11046-016-0058-8.","journal-title":"Mycopathologia"},{"issue":"1","key":"2813_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijd.13423","volume":"57","author":"AM John","year":"2018","unstructured":"John AM, Schwartz RA, Janniger CK. The kerion: an angry tinea capitis. Int J Dermatol. 2018;57(1):3\u20139. https:\/\/doi.org\/10.1111\/ijd.13423.","journal-title":"Int J Dermatol"},{"issue":"3\u20134","key":"2813_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11046-013-9637-0","volume":"76","author":"ETM Mapelli","year":"2013","unstructured":"Mapelli ETM, Cerri A, Bombonato C, Menni S. Tinea capitis in the Paediatric population in Milan, Italy: the emergence of Trichophyton violaceum. Mycopathologia1. 2013;76(3\u20134):243\u20136. https:\/\/doi.org\/10.1007\/s11046-013-9637-0.","journal-title":"Mycopathologia1"},{"issue":"s2","key":"2813_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1439-0507.2007.01424.x","volume":"50","author":"G Ginter-Hanselmayer","year":"2007","unstructured":"Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(s2):6\u201313. https:\/\/doi.org\/10.1111\/j.1439-0507.2007.01424.x.","journal-title":"Mycoses"},{"issue":"2","key":"2813_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.pcl.2013.12.002","volume":"61","author":"L Castelo-Soccio","year":"2014","unstructured":"Castelo-Soccio L. Diagnosis and Management of Alopecia in children. Pediatr Clin N Am. 2014;61(2):427\u201342. https:\/\/doi.org\/10.1016\/j.pcl.2013.12.002.","journal-title":"Pediatr Clin N Am"},{"issue":"4","key":"2813_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/ijt.ijt_92_15","volume":"8","author":"E Elghblawi","year":"2016","unstructured":"Elghblawi E. Idiosyncratic findings in Trichoscopy of tinea capitis: comma, zigzag hairs, corkscrew, and Morse code-like hair. Int J Trichology. 2016;8(4):180\u20133. https:\/\/doi.org\/10.4103\/ijt.ijt_92_15.","journal-title":"Int J Trichology"},{"issue":"11","key":"2813_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/archpedi.153.11.1150","volume":"153","author":"TW Hubbard","year":"1999","unstructured":"Hubbard TW. The predictive value of symptoms in diagnosing childhood tinea capitis. Arch Pediatr Adolesc Med. 1999;153(11):1150\u20133. https:\/\/doi.org\/10.1001\/archpedi.153.11.1150.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"2813_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1525-1470.2010.01137.x","volume":"27","author":"T Kakourou","year":"2010","unstructured":"Kakourou T, Uksal U, Oranje AP. Guidelines for the management of tinea capitis in children. Pediatr Dermatol. 2010;27(3):226\u20138. https:\/\/doi.org\/10.1111\/j.1525-1470.2010.01137.x.","journal-title":"Pediatr Dermatol"},{"key":"2813_CR14","volume-title":"Cochrane database of systematic reviews","author":"U Gonz\u00e1lez","year":"2004","unstructured":"Gonz\u00e1lez U, Seaton T, Bergus G, Torres JM, Jacobson J. Systemic antifungal therapy for tinea capitis in children. In: Gonz\u00e1lez U, editor. Cochrane database of systematic reviews. Chichester: John Wiley & Sons, Ltd; 2004."},{"key":"2813_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.actatropica.2017.12.016","volume":"179","author":"A Peretz","year":"2018","unstructured":"Peretz A, Nitzan O, Freidus V, Kassem R. Tinea capitis-like infection caused by Rhodotorula mucilaginosa in a shelter for African refugee children in northern Israel. Acta Trop. 2018;179:44\u20136. https:\/\/doi.org\/10.1016\/j.actatropica.2017.12.016.","journal-title":"Acta Trop"},{"issue":"7","key":"2813_CR16","first-page":"852","volume":"11","author":"D Bhanusali","year":"2012","unstructured":"Bhanusali D, Coley M, Silverberg JI, Alexis A, Silverberg NB. Treatment outcomes for tinea capitis in a skin of color population. J Drugs Dermatol. 2012;11(7):852\u20136.16.","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"2813_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/myc.12501","volume":"59","author":"J Mashiah","year":"2016","unstructured":"Mashiah J, Kutz A, Ben Ami R, Savion M, Goldberg I, Gan Or T, et al. Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge. Mycoses. 2016;59(9):553\u20137. https:\/\/doi.org\/10.1111\/myc.12501.","journal-title":"Mycoses"},{"issue":"3","key":"2813_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bjd.13196","volume":"171","author":"LC Fuller","year":"2014","unstructured":"Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists\u2019 guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454\u201363. https:\/\/doi.org\/10.1111\/bjd.13196.","journal-title":"Br J Dermatol"},{"issue":"10","key":"2813_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/myc.12970","volume":"62","author":"J Bar","year":"2019","unstructured":"Bar J, Samuelov L, Sprecher E, Mashiah J. Griseofulvin vs terbinafine for paediatric tinea capitis: when and for how long. Mycoses. 2019;62(10):949\u201353. https:\/\/doi.org\/10.1111\/myc.12970.","journal-title":"Mycoses"},{"issue":"4","key":"2813_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaad.2010.02.048","volume":"64","author":"HL Tey","year":"2011","unstructured":"Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64(4):663\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2010.02.048.","journal-title":"J Am Acad Dermatol"},{"key":"2813_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004685.pub2","volume":"4","author":"U Gonzalez","year":"2007","unstructured":"Gonzalez U, Seaton T, Bergus G, Jacobson J, Mart\u0131nez-Monzon C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007;4:CD004685. https:\/\/doi.org\/10.1002\/14651858.CD004685.pub2.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02813-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T05:02:51Z","timestamp":1629954171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02813-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2813"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02813-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"28 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of the Health Maintenance Organization Meuhedet (03\u201329\u201310-18). No permissions were required to access the raw data from the electronic medical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There were no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}